Supreme Court To Decide If Whistle Blowers Can Sue Based On State Data

The pharma industry had reason to cheer when the Supreme Court announced the next round of cases it would take up. Missing from the June 22 order list was a suit challenging reverse settlements between brand and generic manufacturers